European Surgery

, Volume 44, Issue 4, pp 291–295 | Cite as

Selected commentary to "Incidence of adenocarcinoma among patients with Barrett's esophagus"

Selected Commentary


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Becher A, Dent J. Systematic review: ageing and gastro-oesophageal reflux disease symptoms, esophageal function and reflux oesophagitis. Aliment Pharmacol Ther 2011;33(4):442–54PubMedCrossRefGoogle Scholar
  2. Chandrasoma PT. Columnar lined esophagus: what it is and what it tells us. Eur Surg 2006;38(3):197–209CrossRefGoogle Scholar
  3. Lenglinger J, Eisler M, Wrba F, et al. Update: histopathology-based definition of gastroesophageal reflux disease and Barrett's esophagus. Eur Surg 2008;40(4):165–75CrossRefGoogle Scholar
  4. Lenglinger J, Izay B, Eisler M, et al. Barrett's esophagus: size of the problem and diagnostic value of a novel histopathology classification. Eur Surg 2009;41(1):26–39CrossRefGoogle Scholar
  5. Goldblum JR. Controversies in the diagnosis of Barrett esophagus and Barrett-related dysplasia. Arch Pathol Lab Med 2010; 134:1479–84PubMedGoogle Scholar
  6. Odze RD. What the gastroenterologist needs to know about the histology of Barrett's esophagus. Curr Opin Gastroenterol 2011; 27(4):389–96PubMedCrossRefGoogle Scholar
  7. Chandrasoma P, Wijetunge S, DeMeester S, et al. Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenocarcinoma. Am J Surg Pathol 2011;36(1):1–7CrossRefGoogle Scholar
  8. Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population based study. J Natl Cancer Inst 2011;103: 1049–1057PubMedCrossRefGoogle Scholar
  9. Desai TK, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut 2011;61(7):970–76PubMedCrossRefGoogle Scholar
  10. De Jonge PJ, van Blankenstein M, Looman CW, et al. Risk of malignant progression in patients with Barrett's oesophagus: Dutch nationwide cohort study. Gut 2010;59(8):1030–6PubMedCrossRefGoogle Scholar
  11. Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006;4:566–72PubMedCrossRefGoogle Scholar
  12. Wani S, Puli SR, Shaheen NJ, et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systemic review. Am J Gastroenterol 2009; 104:502–13PubMedCrossRefGoogle Scholar
  13. Fleischer DE, Odze R, Overholt BF, et al. The case for endoscopic treatment of non-dysplastic and low grade dysplastic Barrett's esophagus. Dig Dis Sci 2010;55:1918–31PubMedCrossRefGoogle Scholar
  14. Van Vilsteren FGI, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicenter randomized trial. Gut 2011;60(6):765–73PubMedCrossRefGoogle Scholar
  15. Schoppmann SF, Prager G, Langer FB, et al. Open versus minimally invasive esophagectomy: a single-center case controlled study. Surg Endosc 2010;24(12):3044–53PubMedCrossRefGoogle Scholar
  16. Hvid-Jensen F, Pedersen L, Mohr Drewes A, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011;365:1375–83PubMedCrossRefGoogle Scholar
  17. Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinomas: a systematic review. Gastroenterology 2002;122:26–33PubMedCrossRefGoogle Scholar
  18. Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Eng J Med 1999;340 (11):825–31CrossRefGoogle Scholar
  19. Spechler SJ. Screening and surveillance for Barrett's esophagus – an unresolved dilemma. Nat Clin Pract Gastroenterol & Hepatol 2007;4(9):470–1CrossRefGoogle Scholar
  20. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. gastroenterology 2005;129:1825–1831PubMedCrossRefGoogle Scholar
  21. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009;360:2277–88PubMedCrossRefGoogle Scholar
  22. Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011;141:460–68PubMedCrossRefGoogle Scholar
  23. Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow up. Gastrointest Endosc 2008;68(5):867–76PubMedCrossRefGoogle Scholar
  24. Hayeck TJ, Kong CY, Spechler SJ, et al. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esoph 2010;23(6):451–7CrossRefGoogle Scholar
  25. Ferlitsch M, Reinhart K, Pramhas S, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA 2011; 306(12):1352–58PubMedCrossRefGoogle Scholar
  26. Horner MJ, et al. SEER Cancer Statistics Review, 1975–2006, National Cancer Institute. Bethesda, MD,, based on November 2008 SEER data submission, posted to the SEER web site, 2009
  27. Rubenstein JH, Mattek N, Eisen G. Age- and sex-specific yield of Barrett's esophagus by endoscopy indication. Gastrointest Endosc 2010;71:21–27PubMedCrossRefGoogle Scholar
  28. Kadri SR, lao-Sirieix P, O'Donvan, et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 2010;341:c4372PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Department of SurgeryMedical University ViennaViennaAustria

Personalised recommendations